Position in ABBV
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$40,432,257
+$21,803,804 QoQ
Shares Held
160,675
+87.6% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.59%
of 13F equity value
Holder Rank
#418
of 4,153 holders
Holding Since
Dec 2023
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Aware Super Pty Ltd as trustee of Aware Super holds $245,204,463 across 7 Drug Manufacturers - General names. ABBV ranks #3 (16.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
97,248 | $116,642,178 | |
| 2 | JNJ |
Johnson & Johnson
|
160,619 | $40,792,407 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
160,675 | $40,432,257 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
314,669 | $18,131,227 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
117,483 | $14,842,802 | |
| 6 | AMGN |
Amgen Inc
|
24,799 | $8,980,213 | |
| 7 | MRK |
Merck & Co., Inc.
|
41,894 | $5,383,379 |
All Filings in ABBV
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $40,432,257 | 160,675 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $18,628,453 | 85,652 | Shares | Sole | 2026-05-05 | |
| 2025-09-30 | $20,592,241 | 88,936 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $16,508,300 | 88,936 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $18,633,870 | 88,936 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $25,251,525 | 142,102 | Shares | Sole | 2025-02-13 | |
| 2023-12-31 | $14,105,369 | 91,020 | Shares | Sole | 2026-02-12 | |
| No filing history on record for this holder in this stock. | ||||||